vcfirmsdirectory.com

Venture capital · Early stage

AllerFund

AllerFund is a mission-driven, for-profit venture capital firm focused solely on the food allergy community. It backs early-stage companies developing therapies, diagnostics, devices and products for people with food allergies.

New YorkRegistered · New York
New investments · 12 months
Fund vehiclesPublic
3
3 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: allerfund.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round AllerFund joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is AllerFund right for your round?

Is AllerFund a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
3
3 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ALLERFUND I, L.P.US private fund · Active · United States · $17.1M gross assets · filed 18 Mar 2026
ALLERFUND YUMI SPV2, LLCUS private fund · Active · United States · $1.1M gross assets · filed 18 Mar 2026
ALLERFUND YUMI SPV, LLCUS private fund · Active · United States · $811.9K gross assets · filed 18 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds AllerFund joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round AllerFund joined

Round sizes, AllerFund’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

anojaiAtanis BiotechevoendoIgGenixLatitudelibereatReady Set FoodYumi

Portfolio and exits

Every company AllerFund backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where AllerFund puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet AllerFund

Events where AllerFund’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet AllerFund’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

18 Mar 2026Fund filingForm ADV filed by ALLERFUND VENTURES, LLC: 3 private funds, $19M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

AllerFund is based in New York, United States.

3 fund vehicles are on public registers (SEC adviser filings), including ALLERFUND I, L.P., ALLERFUND YUMI SPV2, LLC and ALLERFUND YUMI SPV, LLC.

Stages: Early stage. Sectors: Impact. From the firm’s own website.

The firm aims to create new therapies and products that improve life for people with food allergies. It screens deals like other venture funds but weighs clinical and community impact more heavily. It works with scientists and entrepreneurs to build businesses from promising research, offering business advice and support. From the firm’s own website.

AllerFund lists 8 portfolio companies on its website, including anojai, Atanis Biotech, evoendo, IgGenix and Latitude.

Firms whose websites list some of the same companies include Allumia Ventures, FemHealth Ventures and Good Friends.

Know before AllerFund’s next round is announced.

PRO tracks AllerFund’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

AllerFundGet AllerFund’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.